Atıf Formatları
Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. A. Altinoz Et Al. , "Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies," Journal of Neurosurgical Sciences , vol.68, no.4, pp.468-481, 2024

Altinoz, M. A. Et Al. 2024. Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies. Journal of Neurosurgical Sciences , vol.68, no.4 , 468-481.

Altinoz, M. A., Yilmaz, A., TAGHIZADEHGHALEHJOUGHI, A., Genc, S., Yeni, Y., Gecili, I., ... HACIMÜFTÜOĞLU, A.(2024). Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies. Journal of Neurosurgical Sciences , vol.68, no.4, 468-481.

Altinoz, Meric Et Al. "Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies," Journal of Neurosurgical Sciences , vol.68, no.4, 468-481, 2024

Altinoz, Meric A. Et Al. "Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies." Journal of Neurosurgical Sciences , vol.68, no.4, pp.468-481, 2024

Altinoz, M. A. Et Al. (2024) . "Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies." Journal of Neurosurgical Sciences , vol.68, no.4, pp.468-481.

@article{article, author={Meric A. Altinoz Et Al. }, title={Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies}, journal={Journal of Neurosurgical Sciences}, year=2024, pages={468-481} }